A Study of Fluoxetine in Major Depressive Disorder (MDD) Long-Term Dosing
NCT01808651
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
200
Enrollment
INDUSTRY
Sponsor class
Conditions
Major Depressive Disorder
Interventions
DRUG:
Fluoxetine
Sponsor
Eli Lilly and Company